Learn More
Medchemexpress LLC Protac pan-AKT degrader (ipatasertib-lenalidomide conjugate) | 2503017-97-6 | 99.7% | 798.41 g·mol⁻¹ | C44H56ClN7O5 | 5 MG

Supplier: Medchemexpress LLC HY1331205MG
A potent, selective PROTAC-based pan-AKT degrader that links an ATP-competitive AKT inhibitor to a cereblon ligand to induce degradation of AKT1, AKT2, and AKT3. It is supplied as a white to off-white solid for research use in biochemical and cellular studies of AKT signaling and degradation mechanisms.
- Potent degradation of AKT isoforms with low-nanomolar activity.
- High chemical purity (≈99.7%).
- Molecular weight 798.41 g·mol⁻¹ and formula C44H56ClN7O5.
- White to off-white solid form.
- Storage: sealed, away from moisture; in solvent -80°C up to 6 months, -20°C up to 1 month.
- Suitable for biochemical and cellular AKT pathway studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.